US FDA Mum On Whether Woodcock Would Stick Around Long-Term For Califf

 
• By Sarah Karlin-Smith and Derrick Gingery
Janet Woodcock
Janet Woodcock addressed her future plans during a session at the recent Biopharma Congress. • Source: screenshot

More from US FDA

More from Agency Leadership